Journal of Clinical Psychopharmacology

Aims & Scope

Journal of Clinical Psychopharmacology, a leading publication in psychopharmacology, offers a wide range of articles reporting on clinical trials and studies, side effects, drug interactions, overdose management, pharmacogenetics, pharmacokinetics, and psychiatric effects of non-psychiatric drugs.

The journal keeps clinician-scientists and trainees up-to-date on the latest clinical developments in psychopharmacologic agents, presenting the extensive coverage needed to keep up with every development in this fast-growing field.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.8
2024	2.90

SJR (SCImago Journal Rank)

Year	Value
2024	0.725

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	135

Journal Rank

Year	Value
2024	7754

Journal Citation Indicator

Year	Value
2024	625

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Digit Symbol Substitution Test

  Citation: 668

  Authors: Judith

• A Canadian Multicenter Placebo-Controlled Study of Fixed Doses of Risperidone and Haloperidol in the Treatment of Chronic Schizophrenic Patients

  Citation: 613

  Authors: GUY, BARRY, GARY, DAVID, DONALD, G. WILLIAM, ALAIN, LINDA, WENDY

• Double-Blind Comparison of Olanzapine Versus Risperidone in the Treatment of Schizophrenia and Other Psychotic Disorders

  Citation: 533

  Authors: Pierre V., Susan H., Amy J., Janet H., Scott W., Charles Jr, Gary D.

• Effects of SSRIs on Sexual Function

  Citation: 509

  Authors: Raymond C., Roger M., Matthew

• Six-Month Randomized, Placebo-Controlled, Double-Blind, Pilot Clinical Trial of Curcumin in Patients With Alzheimer Disease

  Citation: 491

  Authors: Larry, Christopher Wai Kei, Stanley Kwok-Kuen, Timothy, Victor, Joshua, Linda, Vivian, Elsie, Chelsia, Jean, Helen Fung Kum, William B., Benny Chung-Ying, King Fai, Carmen Yuet Shim, Adrian, Hazel, Moses Sing Sum, Ping Chuen, Siu Po, Chung Shun, Xiong Wen, Caroline Yau Lin, Ming-Houng, Samuel, Iris Hiu Shuen, Vincent

• Treatment-Emergent Sexual Dysfunction Related to Antidepressants

  Citation: 466

  Authors: Alessandro, Alberto

• An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder

  Citation: 434

  Authors: Sheldon H., Bryan, Sheela, Frank S., Michael, Jaren W.

• Efficacy of Quetiapine Monotherapy in Bipolar I and II Depression

  Citation: 426

  Authors: Michael E., Wayne, Richard H., William, Björn, Arifulla, Joseph R.

• Validity and Reliability of the Observer??s

  Citation: 418

  Authors: DORIS A., DENNIS, HARRIET, JUDITH, JONATHAN M., ARNOLD B., ELIAS M., JUDITH L.

• Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression

  Citation: 388

  Authors: Rafael Faria, Flávia, Rafael G., Ligia R.H., João Paulo, Lauro, Draulio Barros, Jordi, José Alexandre S., Jaime E.C.

---